US4990457A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Whole blood dry analysis element
Assignee: Fujifilm Holdings Corp
•
Filing: 1989-04-04
•
Granted: 1991-02-05
•
Expires: 2009-04-04
Abstract
Abstract A dry analysis element for determination of a particular constituent in erythrocyte-containing blood, which comprises at least a water permeable porous spreading layer and a water permeable reagent layer arranged on the side opposite to the liquid accepting face of the porous spreading layer, and which contains a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least either of the water permeable layers. The porous spreading layer contains cholic acid, deoxycholic acid or salts thereof to enable accurate determination of the constituents in whole blood, irrespective of the hematocrit value.
Inventors
- 👤 Mitsutoshi Tanaka
- 👤 Takaki Arai
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 18:21
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; G01N33/525; Y; Y10; Y10S; Y10S435/00; Y10S435/805
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
124 words
A dry analysis element for the determination of a component in erythrocyte-containing blood which comprises at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face for the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 2
Dependent Claim
124 words
A dry analysis element for the determination of a component in erythrocyte-containing blood which comprises at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face for the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 3
Dependent Claim
19 words
The analysis element of claim 1 wherein said porous spreading layer contains an alkali metal salt of deoxycholic acid.
Claim 4
Dependent Claim
35 words
The analysis element of claim 1 wherein the compound is selected from the group consisting of cholic acid, lithocholic acid, taurocholic acid, glycocholic acid, deoxycholic acid, chenodeoxycholic acid, taurodeoxycholic acid, glycodeoxy-cholic acid, and their salts.
Claim 5
Dependent Claim
14 words
The analysis element of claim 3 wherein the salt is an alkali metal salt.
Claim 6
Dependent Claim
21 words
The analysis element of claim 4 wherein the alkali metal salt is selected from the group consisting of sodium and potassium.
Claim 7
Dependent Claim
21 words
The analysis element of claim 1 wherein the amount of said compound is from about 0.5 to 6 g/m 2 .
Claim 8
Dependent Claim
21 words
The analysis element of claim 6 wherein the amount of said compound is from about 1 to 4 g/m 2 .
Claim 9
Dependent Claim
155 words
In a method for the analysis of a component in an erythrocyte-containing blood sample wherein a droplet size sample of the blood is introduced to a dry analysis element and the quantity of the component is determined by optical analysis, the improvement which comprises said element having at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face of the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water-permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 10
Dependent Claim
155 words
In a method for the analysis of a component in an erythrocyte-containing blood sample wherein a droplet size sample of the blood is introduced to a dry analysis element and the quantity of the component is determined by optical analysis, the improvement which comprises said element having at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face of the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water-permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 11
Dependent Claim
12 words
The method of claim 8 wherein non-hydrophobic constituents in blood are determined.
Claim 12
Dependent Claim
11 words
The method of claim 8 wherein saccharides in blood are determined.
Claim 13
Dependent Claim
11 words
The method of claim 8 wherein glucose in blood is determined.
Claim 14
Dependent Claim
18 words
The method of claim 8 wherein said porous spreading layer contains an alkali metal salt of deoxycholic acid.
Claim 15
Dependent Claim
34 words
The method of claim 8 wherein the compound is selected from the group consisting of cholic acid, lithocholic acid, taurocholic acid, glycocholic acid, deoxycholic acid, chenodeoxycholic acid, taurodeoxycholic acid, glycodeoxycholic acid, and their salts.
Claim 16
Dependent Claim
13 words
The method of claim 8 wherein the salt is an alkali metal salt.
Claim 17
Dependent Claim
20 words
The method of claim 8 wherein the alkali metal salt is selected from the group consisting of sodium and potassium.
Claim 18
Dependent Claim
20 words
The method of claim 8 wherein the amount of said compound is from about 0.5 to 6 g/m 2 .
Claim 19
Dependent Claim
20 words
The method of claim 8 wherein the amount of said compound is from about 1 to 4 g/m 2 .
Claim 20
Dependent Claim
23 words
The method of claim 8 wherein the blood to be analyzed has a hematocrit value in the range from about 25 to 70%.
References Cited (Backward Citations)
US4777139A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-02-04 | 1994-08-06 | 1995-02-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-02-04 | 1998-08-06 | 1999-02-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-02-04 | 2002-08-06 | 2003-02-05 | $7700.00 | Window Closed / Lapsed |